| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |